MGLIX
Price
$16.62
Change
+$0.06 (+0.36%)
Updated
Jun 12 closing price
Net Assets
2.3B
POSIX
Price
$9.73
Change
+$0.06 (+0.62%)
Updated
Jun 12 closing price
Net Assets
1.71B
Interact to see
Advertisement

MGLIX vs POSIX

Header iconMGLIX vs POSIX Comparison
Open Charts MGLIX vs POSIXBanner chart's image
MFS Global Real Estate I
Price$16.62
Change+$0.06 (+0.36%)
VolumeN/A
Net Assets2.3B
Principal Global Real Estate Sec Instl
Price$9.73
Change+$0.06 (+0.62%)
VolumeN/A
Net Assets1.71B
MGLIX vs POSIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGLIX vs. POSIX commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLIX is a Buy and POSIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.3B vs. POSIX (1.71B). MGLIX (2.53) and POSIX (2.44) have matching dividends . MGLIX was incepted earlier than POSIX: MGLIX (16 years) vs POSIX (18 years). POSIX (1.01) is less costly to investors than MGLIX (0.95). MGLIX is a more actively managed with annual turnover of: 48.00 vs. POSIX (27.50). MGLIX (0) and POSIX (0) have matching initial minimum investment requirements. POSIX annual gain was more profitable for investors over the last year : 10.31 vs. MGLIX (5.08). POSIX return over 5 years is better than : 21.21 vs. MGLIX (15.64).
MGLIXPOSIXMGLIX / POSIX
Total Expense Ratio0.940.9599%
Annual Report Gross Expense Ratio0.951.0194%
Fund Existence16 years18 years-
Gain YTD3.2426.03154%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.3B1.71B135%
Annual Yield % from dividends2.532.44104%
Returns for 1 year5.0810.3149%
Returns for 3 years1.0313.118%
Returns for 5 years15.6421.2174%
Returns for 10 years32.4934.0595%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEMYX16.13N/A
N/A
Putnam Emerging Markets Equity Y
FBTAX26.55N/A
N/A
Fidelity Advisor Biotechnology A
RYWCX38.58N/A
N/A
Rydex S&P SmallCap 600 Pure Growth C
ACSCX9.52N/A
N/A
American Century Small Cap Value A
VVJEX11.27N/A
N/A
Voya VACS Series MCV Fund